Skip to main content
Caplight Logo









MC Sciences

MC Sciences

Private
MeckenheimHealthcare & Life Scienceshttps://mcsciences.com/

Last Round

Series A

Apr 1, 2026

Total Funding Raised

$5M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

MC Sciences is a biotechnology company that develops first-in-class therapeutics targeting mast cells to treat a variety of diseases including immunology, dermatology, respiratory, and gastrointestinal conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologymast cell therapeuticsdrug discoverysmall-molecule drugsmonoclonal antibodiesbiopharmainflammatory disease treatmentneuroinflammationclinical-stage biotechprecision medicinemAbsdrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MC Sciences Comparables

Compare MC Sciences with similar companies based on industry and business-model similarity.

MC Sciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Allegria Therapeutics AG
89%
Alys Pharmaceuticals
82%
Evommune
81%

MC Sciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 1, 2026
SeedApr 15, 2022

Key People

Founding team and executive leadership

Michael Mark

Chief Executive Officer

Executive Team

MC Sciences Investors

Notable investors and investment history

MC Sciences investors
InvestorRounds
ROC Venture GroupSeed, Series A
LifeArc VenturesSeed, Series A
Bayern KapitalSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2026

    Raised Series A with Bayern Kapital, LifeArc Ventures, and ROC Venture Group.

  • Apr 15, 2022

    $5M raised from Bayern Kapital, LifeArc Ventures, and ROC Venture Group.

MC Sciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MC Sciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MC Sciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersMeckenheim
Employee Range7
Year Founded2020
Last FundingApr 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?